morpholinoanthracycline mx2 has been researched along with Leukopenia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuraishi, Y; Ogawa, M; Okabe, K; Sampi, K; Takemoto, Y; Tamura, K | 1 |
Arita, N; Kayama, T; Kubo, N; Kuratsu, JI; Mori, T; Sawamura, Y; Ushio, Y | 1 |
Majima, H | 1 |
Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Mizunuma, N; Mukaiyama, T; Nagamine, D; Ogawa, M; Shinagawa, K; Tabata, M | 1 |
2 trial(s) available for morpholinoanthracycline mx2 and Leukopenia
Article | Year |
---|---|
[Phase II study of KRN8602 (MX2) for malignant lymphoma].
Topics: Anorexia; Antibiotics, Antineoplastic; Carubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Nausea; Thrombocytopenia; Vomiting | 1998 |
Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients.
Topics: Adult; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Cardiomyopathies; Carubicin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Glioblastoma; Humans; Leukopenia; Male; Middle Aged; Nausea; Oligodendroglioma; Treatment Outcome; Vomiting | 2000 |
2 other study(ies) available for morpholinoanthracycline mx2 and Leukopenia
Article | Year |
---|---|
[Phase I clinical study of MX2 (KRN 8602)].
Topics: Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Vomiting | 1990 |
[Phase I and pharmacokinetic study of KRN8602, a new morpholino anthracycline].
Topics: Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carubicin; Drug Evaluation; Female; Hodgkin Disease; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1989 |